Discovery of novel oridonin sulfamide derivatives as potent NLRP3 inhibitors by a visible-light photocatalysis-enabled peripheral editing

Bioorg Med Chem Lett. 2024 Feb 1:99:129621. doi: 10.1016/j.bmcl.2024.129621. Epub 2024 Jan 18.

Abstract

The progress of organicsyntheticmethod can promote late-stage lead compound modification and novel active compound discovery. Molecular editing technology in the field of organic synthesis, including peripheral and skeletal editing, facilitates rapid access to molecular diversity of a lead compound. Peripheral editing of CH bond activation is gradually used in lead optimization to afford novel active scaffolds and chemical space exploitation. To develop oridonin derivatives with high anti-inflammatory potency, novel oridonin sulfamides had been designed and synthesized by a scaffoldhopping strategy based on a visible-light photocatalysis peripheral editing. All novel compounds revealed measurable inhibition of IL-1β and low cytotoxicity in THP-1 cells. The docking study indicated that the best active compound ZM640 was accommodated in thebinding site of NLRP3 with two hydrogen bond interaction. These preliminary results confirm that α, β-unsaturated carbonyl of oridonin is not essential for NLRP3 inhibitory effect. This new oridonin scaffold has its potential to be further developed as a promising class of NLRP3 inhibitors.

Keywords: Anti-inflammatory activity; NLRP3 inhibitor; Oridonin; Peripheral editing.

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Chemistry Techniques, Synthetic
  • Diterpenes, Kaurane* / chemistry
  • Diterpenes, Kaurane* / pharmacology
  • NLR Family, Pyrin Domain-Containing 3 Protein

Substances

  • oridonin
  • Antineoplastic Agents
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Diterpenes, Kaurane